NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS – NOTE 11

11. INVESTMENT IN SUBSIDIARIES
 
  GROUP   COMPANY  
  June 2017
R’000
  June 2016
R’000
  June 2017
R’000
  June 2016
R’000
 
Unlisted investments at cost     428 144   428 144  

Name Main
business
  Country of
incorporation
  Interest held     
(voting rights)    
 
2017 and 2016            
Directly held            
AfroCentric Resources (Pty) Ltd Dormant   South Africa   100%      
AfroCentric Capital (Pty) Ltd Dormant   South Africa   100%      
ACT Healthcare Assets (Pty) Ltd Investment holding   South Africa   71.3%**  
ACT Funding (Pty) Ltd Financing   South Africa   100%      
Indirectly held            
AfroCentric Health (Pty) Ltd Healthcare Administration   South Africa   71.3%      

The indirectly held subsidiary, Medscheme Holdings Proprietary Limited, owned by AfroCentric Health Proprietary Limited, operates in the healthcare administration industry. The total aggregate assets, liabilities and results of Medscheme Holdings Proprietary Limited’s operations are summarised as follows:

Summarised statement of financial position of Medscheme Holdings Proprietary Limited:

  GROUP  
  June 2017
R’000
  June 2016
R’000
 
Non-current assets (excluding intangible assets) 158 491   149 183  
Intangible assets 18 777   15 079  
Current assets 950 271   725 973  
Total assets 1 127 539   890 235  
Non-current liabilities 27 850   22 764  
Current liabilities 235 681   219 484  
Total liabilities 263 531   242 248  

Summarised statement of comprehensive income of Medscheme Holdings Proprietary Limited:

  GROUP  
  June 2017
R’000
  June 2016
R’000
 
Revenue 2 008 106   1 860 722  
Profit for the period 216 194   137 889  
Other comprehensive (loss)/income (285)   206  
Total comprehensive income 215 909   138 095  

Summarised statement of cash flows of Medscheme Holdings Proprietary Limited:

  GROUP  
  June 2017
R’000
  June 2016
R’000
 
Net cash inflow from operating activities 309 744   66 108  
Net cash outflow from investing activities (188 432)   (222 380)  
Net cash inflow from financing activities 1 234   36 468  
Net decrease in cash and cash equivalents (122 546)   (119 804)  
** During the prior year, the Company’s shareholding in ACT Healthcare Assets Proprietary Limited was diluted to 71.3% as a result of a share issue to Sanlam. The proceeds on disposal of R703 million were received in cash. An amount of R456.3 million (being the proportionate share of the carrying amount of the net assets of ACT Healthcare Assets Proprietary Limited has been transferred to non-controlling interest (Note 16). The difference of R246.6 million between the increase in the non-controlling interest and the consideration received has been credited directly to equity.

NOTES TO THE GROUP ANNUAL FINANCIAL STATEMENTS – NOTE 11